News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

HitGen and Viva Biotech Team Up to Provide Early-Stage CRO Services



12/27/2012 11:24:43 AM

by Richard Daverman, PhD

December 24, 2012 -- HitGen Ltd. and Viva Biotech Ltd., two China CROs specializing in early-stage services, announced a new collaboration. HitGen, located in Chengdu, offers lead generation services. VivaBiotech of Shanghai is a structure-based drug discovery CRO. According to the two companies, their now-integrated early hit-to lead generation program addresses a previously unmet need in China’s pre-clinical drug discovery sector. More details....


Read at ChinaBio Today


comments powered by Disqus
HitGen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES